by James Lyons-Weiler, PhD, Popular Rationalism, ©2025
(Dec. 22, 2025) — A new E. americana study is proof-of-concept that a live bacterium, selectively colonizing tumors, can initiate robust tumor-specific immune memory via presentation of novel peptides in an inflammatory context. This is precisely the kind of “danger signal” required for overcoming T cell anergy and immune ignorance toward tumors.
Each year, cancer claims over 600,000 lives in the United States alone. Globally, the toll exceeds 10 million deaths annually, making it the second leading cause of death worldwide. And yet, in the shadow of that sobering figure, it is rare—exceptionally rare—for the public to witness a preclinical experiment so elegant, so disciplined, and so brimming with translational promise as the recent study published in Gut Microbes (2025): “Discovery and characterization of antitumor gut microbiota from amphibians and reptiles: Ewingella americana as a novel therapeutic agent with dual cytotoxic and immunomodulatory properties” (DOI: 10.1080/19490976.2025.2599562).
It is not often that baterial isolates from a frog’s intestine lights a path forward for human cancer therapy. But that is precisely what happened.
The Core Breakthrough
For this discovery, researchers led by Seigo Iwata and Eijiro Miyako from Japan Advanced Institute of Science and Technology (JAIST), specifically at the Graduate School of Advanced Science and Technology, sifted through and carefully studied 45 bacterial isolates drawn from the guts of amphibians and reptiles. They identified Ewingella americana as a standout: a naturally occurring, non-engineered bacterium capable of completely eliminating established colorectal tumors in immunocompetent mice after a single intravenous dose. Mice were injected with Colon-26 carcinoma cells, a syngeneic colorectal tumor line, and were then treated once tumors reached ~200 mm^3. Each candidate bacterial strain was administered via tail vein at a standard dose (200 μL of 5 × 10^9 CFU/mL (colony-forming units/milliliter). Tumors were monitored for 40 days.
Read the rest here.